Senda Biosciences Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Senda Biosciences's estimated annual revenue is currently $8.8M per year.(i)
  • Senda Biosciences's estimated revenue per employee is $155,000

Employee Data

  • Senda Biosciences has 57 Employees.(i)
  • Senda Biosciences grew their employee count by -42% last year.

Senda Biosciences's People

NameTitleEmail/Phone
1
Sr VP, Human ResourcesReveal Email/Phone
2
SVP, CMCReveal Email/Phone
3
VP, Process DevelopmentReveal Email/Phone
4
Head StrategyReveal Email/Phone
5
Head Business DevelopmentReveal Email/Phone
6
Head Medicinal ChemistryReveal Email/Phone
7
VP, Translational MedicineReveal Email/Phone
8
Head Intellectual PropertyReveal Email/Phone
9
General CounselReveal Email/Phone
10
Chief Platform OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Senda Biosciences?

Senda Biosciences is pioneering the field of Intersystems Biology to create novel treatments for human disease. Intersystems Biology focuses on how molecular connections between botanical, bacterial, and human cells—coevolved over millennia—define health and disease. Senda's Intersytems Biology discovery platform, built using new techniques in machine learning and computational biology, has been able to generate novel, actionable insights into the trillions of interspecies molecular connections in the human body, and harnesses the power of this “pharmacy within us” with novel pharmacological approaches. The power of the Senda platform is illustrated by six preclinical programs in oncology, neurology, chronic disease, and metabolic disease. Senda was founded by Flagship Labs, the innovation foundry of Flagship Pioneering. To learn more, please visit the company's website at www.sendabiosciences.com.

keywords:N/A

N/A

Total Funding

57

Number of Employees

$8.8M

Revenue (est)

-42%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Senda Biosciences News

2022-04-06 - Microbiome biotech Kaleido Biosciences shutters amid cash crunch ...

Flagship-founded startup Senda Biosciences analyzes the interactions between humans and bacteria but does not call itself a microbiome...

2022-02-22 - Senda Biosciences Appoints Stuart Milstein, Ph.D., as SVP and ...

Senda Biosciences, Inc. is uniquely positioned to transform human health by harnessing millions of years of evolution to program targeted,...

2021-06-11 - Senda Biosciences Closes $98M Series B Financing

Senda Biosciences, a Cambridge, Mass.-based company that harnesses the molecular interactions between humans, plants, and bacteria to develop new types of medicines, raised a $55m Series B extension financing, bringing its total Series B funding to $98m and total funding raised to date to $143m. ...

2021-06-10 - Senda Biosciences : Announces Closing of $98 Million Series B Financing

CAMBRIDGE, Mass., June 10, 2021 /PRNewswire/ -- Senda Biosciences, a company that is systematically harnessing the powerful molecular interactions that have evolved over millennia between humans, plants, and bacteria to develop new types of medicines, announced today the completion of a $55 mill ...

2021-06-10 - Senda Biosciences Announces Closing of $98 Million Series B Financing

CAMBRIDGE, Mass., June 10, 2021 /PRNewswire/ -- Senda Biosciences, a company that is systematically harnessing the powerful molecular interactions that have evolved over millennia between humans, plants, and bacteria to develop new types of medicines, announced today the completion of a $55 mi ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.9M57-21%$50.7M
#2
$12.1M5750%$195M
#3
$8.4M57-16%$40.7M
#4
$5.2M57-3%N/A
#5
$13M57-10%N/A